Free Trial

iSpecimen (ISPC) Competitors

iSpecimen logo
$1.15 -0.03 (-2.54%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$1.16 +0.01 (+0.52%)
As of 03/28/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ISPC vs. HLGN, MRIN, BIAF, XYLO, SOPA, FTFT, SYRA, BAOS, ATXG, and TCJH

Should you be buying iSpecimen stock or one of its competitors? The main competitors of iSpecimen include Heliogen (HLGN), Marin Software (MRIN), bioAffinity Technologies (BIAF), Xylo Technologies (XYLO), Society Pass (SOPA), Future FinTech Group (FTFT), Syra Health (SYRA), Baosheng Media Group (BAOS), Addentax Group (ATXG), and Top KingWin (TCJH). These companies are all part of the "business services" industry.

iSpecimen vs.

Heliogen (NYSE:HLGN) and iSpecimen (NASDAQ:ISPC) are both small-cap energy companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations, risk and community ranking.

iSpecimen received 3 more outperform votes than Heliogen when rated by MarketBeat users. Likewise, 75.00% of users gave iSpecimen an outperform vote while only 0.00% of users gave Heliogen an outperform vote.

CompanyUnderperformOutperform
HeliogenOutperform Votes
No Votes
Underperform Votes
4
100.00%
iSpecimenOutperform Votes
3
75.00%
Underperform Votes
1
25.00%

iSpecimen has higher revenue and earnings than Heliogen. iSpecimen is trading at a lower price-to-earnings ratio than Heliogen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heliogen$3.92M1.38-$129.60M-$20.81-0.04
iSpecimen$10.39M0.11-$11.10M-$19.10-0.06

Heliogen has a beta of 2.79, suggesting that its share price is 179% more volatile than the S&P 500. Comparatively, iSpecimen has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500.

27.6% of Heliogen shares are held by institutional investors. Comparatively, 13.6% of iSpecimen shares are held by institutional investors. 3.8% of Heliogen shares are held by company insiders. Comparatively, 12.2% of iSpecimen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Heliogen has a net margin of 0.00% compared to iSpecimen's net margin of -91.66%. Heliogen's return on equity of 0.00% beat iSpecimen's return on equity.

Company Net Margins Return on Equity Return on Assets
HeliogenN/A N/A -147.90%
iSpecimen -91.66%-139.25%-73.97%

In the previous week, iSpecimen had 2 more articles in the media than Heliogen. MarketBeat recorded 2 mentions for iSpecimen and 0 mentions for Heliogen. iSpecimen's average media sentiment score of 1.44 beat Heliogen's score of 0.00 indicating that iSpecimen is being referred to more favorably in the news media.

Company Overall Sentiment
Heliogen Neutral
iSpecimen Positive

Summary

iSpecimen beats Heliogen on 9 of the 15 factors compared between the two stocks.

Remove Ads
Get iSpecimen News Delivered to You Automatically

Sign up to receive the latest news and ratings for ISPC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ISPC vs. The Competition

MetriciSpecimenCommercial physical research IndustryMedical SectorNASDAQ Exchange
Market Cap$1.11M$3.65B$5.63B$7.83B
Dividend YieldN/A2.02%4.57%4.00%
P/E Ratio-0.06111.7723.3318.67
Price / Sales0.11158.88388.4691.01
Price / CashN/A34.5738.1634.64
Price / Book0.052.536.894.23
Net Income-$11.10M$118.81M$3.20B$247.15M
7 Day Performance-16.06%-5.45%-3.02%-2.17%
1 Month Performance-30.72%-20.87%1.63%-5.68%
1 Year Performance395.69%-12.70%9.74%-0.67%

iSpecimen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ISPC
iSpecimen
1.262 of 5 stars
$1.15
-2.5%
N/A+395.7%$1.11M$10.39M-0.0660Short Interest ↓
Gap Up
HLGN
Heliogen
N/A$0.83
-5.7%
N/A-38.3%$5.02M$3.92M-0.045,305Gap Down
MRIN
Marin Software
1.1476 of 5 stars
$1.45
+3.6%
N/A-24.6%$4.56M$16.71M-0.37180Short Interest ↓
Gap Up
BIAF
bioAffinity Technologies
2.3256 of 5 stars
$0.29
+4.3%
$6.00
+1,981.9%
-87.0%$4.49M$9.37M-0.3510Short Interest ↑
News Coverage
XYLO
Xylo Technologies
1.2293 of 5 stars
$5.10
-1.0%
N/AN/A$4.17M$57.64M0.0030Short Interest ↓
News Coverage
SOPA
Society Pass
3.5137 of 5 stars
$1.13
-2.6%
$16.00
+1,315.9%
-59.4%$4.12M$6.91M-0.222,021Short Interest ↓
Gap Down
FTFT
Future FinTech Group
0.2587 of 5 stars
$0.20
+3.7%
N/A-83.0%$4.09M$18.54M0.0070Short Interest ↑
Gap Up
SYRA
Syra Health
0.7729 of 5 stars
$0.33
+1.8%
N/A-79.4%$3.75M$7.98M-0.5178Short Interest ↓
BAOS
Baosheng Media Group
1.6819 of 5 stars
$2.43
+8.0%
N/A-35.3%$3.73M$859,226.000.00130Short Interest ↓
ATXG
Addentax Group
1.7839 of 5 stars
$0.83
+5.1%
N/A-7.1%$3.56M$4.55M-2.96130Gap Up
TCJH
Top KingWin
N/A$0.23
+0.8%
N/A-85.4%$3.39M$3.99M0.00145Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:ISPC) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners